Review ArticleReviews and Commentaries

Omega-3s and Cardiovascular Health

James J. DiNicolantonio, Asfandyar K. Niazi, Mark F. McCarty, James H. O'Keefe, Pascal Meier and Carl J. Lavie
Ochsner Journal September 2014, 14 (3) 399-412;

REFERENCES

  1. ↵
    1. Kromhout D,
    2. Bosschieter EB
    (5 9, 1985) de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312(19):1205–1209, pmid:3990713.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Delgado-Lista J,
    2. Perez-Martinez P,
    3. Lopez-Miranda J,
    4. Perez-Jimenez F
    (6, 2012) Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107((suppl 2)):S201–S213, pmid:22591894.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Stone NJ
    (11 1, 1996) Fish consumption, fish oil, lipids, and coronary heart disease. Circulation 94(9):2337–2340, pmid:8901708.
    OpenUrlFREE Full Text
  4. ↵
    1. DiNicolantonio JJ,
    2. Niazi AK,
    3. O'Keefe JH,
    4. Lavie CJ
    (12, 2013) Explaining the recent fish oil trial “failures.” J Glycomics Lipidomics 3(1), Epub 2012 Nov 15. .
  5. ↵
    1. Harris WS,
    2. Bulchandani D
    (8, 2006) Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17(4):387–393, pmid:16832161.
    OpenUrlCrossRefPubMed
    1. Harris WS,
    2. Muzio F
    (7, 1993) Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. Am J Clin Nutr 58(1):68–74, pmid:8317392.
    OpenUrlAbstract/FREE Full Text
    1. Harris WS,
    2. Connor WE,
    3. Alam N,
    4. Illingworth DR
    (11, 1988) Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res 29(11):1451–1460, pmid:3241121.
    OpenUrlAbstract
    1. Schirmer SH,
    2. Werner CM,
    3. Binder SB,
    4. et al.
    (11, 2012) Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation. Atherosclerosis 225(1):166–172, pmid:23017356, Epub 2012 Sep 13.
    OpenUrlCrossRefPubMedWeb of Science
    1. Volek JS,
    2. Gómez AL,
    3. Kraemer WJ
    (6, 2000) Fasting lipoprotein and postprandial triacylglycerol responses to a low-carbohydrate diet supplemented with n-3 fatty acids. J Am Coll Nutr 19(3):383–391, pmid:10872901.
    OpenUrlPubMedWeb of Science
    1. Harris WS,
    2. Hustvedt BE,
    3. Hagen E,
    4. Green MH,
    5. Lu G,
    6. Drevon CA
    (3, 1997) N-3 fatty acids and chylomicron metabolism in the rat. J Lipid Res 38(3):503–515, pmid:9101431.
    OpenUrlAbstract
    1. Roche HM,
    2. Gibney MJ
    (1, 1999) Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state. Lipids 34((1)(suppl)):S259–S265, pmid:10419173.
    OpenUrlCrossRefPubMed
    1. Qi K,
    2. Fan C,
    3. Jiang J,
    4. et al.
    (6, 2008) Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Clin Nutr 27(3):424–430, pmid:18362042, Epub 2008 Mar 24.
    OpenUrlCrossRefPubMedWeb of Science
    1. Sanders TA,
    2. Oakley FR,
    3. Miller GJ,
    4. Mitropoulos KA,
    5. Crook D,
    6. Oliver MF
    (12, 1997) Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors. Arterioscler Thromb Vasc Biol 17(12):3449–3460, pmid:9437192.
    OpenUrlAbstract/FREE Full Text
    1. Smith BK,
    2. Sun GY,
    3. Donahue OM,
    4. Thomas TR
    (10, 2004) Exercise plus n-3 fatty acids: additive effect on postprandial lipemia. Metabolism 53(10):1365–1371, pmid:15375796.
    OpenUrlCrossRefPubMedWeb of Science
    1. Mozaffarian D,
    2. Wu JH
    (11 8, 2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58(20):2047–2067, pmid:22051327.
    OpenUrlFREE Full Text
    1. Geleijnse JM,
    2. Giltay EJ,
    3. Grobbee DE,
    4. Donders AR,
    5. Kok FJ
    (8, 2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20(8):1493–1499, pmid:12172309.
    OpenUrlCrossRefPubMedWeb of Science
    1. Mozaffarian D,
    2. Geelen A,
    3. Brouwer IA,
    4. Geleijnse JM,
    5. Zock PL,
    6. Katan MB
    (9 27, 2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112(13):1945–1952, pmid:16172267, Epub 2005 Sep 19.
    OpenUrlAbstract/FREE Full Text
    1. O'Keefe JH Jr.,
    2. Abuissa H,
    3. Sastre A,
    4. Steinhaus DM,
    5. Harris WS
    (4 15, 2006) Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 97(8):1127–1130, pmid:16616012, Epub 2006 Mar 3.
    OpenUrlCrossRefPubMedWeb of Science
    1. Djoussé L,
    2. Akinkuolie AO,
    3. Wu JH,
    4. Ding EL,
    5. Gaziano JM
    (12, 2012) Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin Nutr 31(6):846–853, pmid:22682084, Epub 2012 Jun 6.
    OpenUrlCrossRefPubMed
    1. Charnock JS,
    2. McLennan PL,
    3. Abeywardena MY
    (10 21, 1992) Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem 116((1-2)):19–25, pmid:1480148.
    OpenUrlCrossRefPubMedWeb of Science
    1. Ghio S,
    2. Scelsi L,
    3. Latini R,
    4. et al.
    (12, 2010) Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 12(12):1345–1353, pmid:20952767, Erratum in: Eur J Heart Fail. 2011 Sep;13(9):1042.
    OpenUrlCrossRefPubMed
    1. Grimsgaard S,
    2. Bønaa KH,
    3. Hansen JB,
    4. Myhre ES
    (7, 1998) Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 68(1):52–59, pmid:9665096.
    OpenUrlAbstract
    1. McLennan PL,
    2. Barnden LR,
    3. Bridle TM,
    4. Abeywardena MY,
    5. Charnock JS
    (9, 1992) Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc Res 26(9):871–877, pmid:1451164.
    OpenUrlCrossRefPubMedWeb of Science
    1. Mozaffarian D,
    2. Gottdiener JS,
    3. Siscovick DS
    (1 15, 2006) Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 97(2):216–222, pmid:16442366, Epub 2005 Nov 21.
    OpenUrlCrossRefPubMedWeb of Science
    1. Peoples GE,
    2. McLennan PL,
    3. Howe PR,
    4. Groeller H
    (12, 2008) Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 52(6):540–547, pmid:19034030.
    OpenUrlCrossRefPubMedWeb of Science
    1. Pepe S,
    2. McLennan PL
    (5 14, 2002) Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 105(19):2303–2308, pmid:12010914.
    OpenUrlAbstract/FREE Full Text
    1. Xin W,
    2. Wei W,
    3. Li X
    (11, 2012) Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials. Heart 98(22):1620–1625, pmid:22760864, Epub 2012 Jul 3.
    OpenUrlAbstract/FREE Full Text
    1. Nodari S,
    2. Triggiani M,
    3. Campia U,
    4. et al.
    (2 15, 2011) Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 57(7):870–879, pmid:21215550, Epub 2011 Jan 6.
    OpenUrlFREE Full Text
    1. Hein GJ,
    2. Bernasconi AM,
    3. Montanaro MA,
    4. et al.
    (3, 2010) Nuclear receptors and hepatic lipidogenic enzyme response to a dyslipidemic sucrose-rich diet and its reversal by fish oil n-3 polyunsaturated fatty acids. Am J Physiol Endocrinol Metab 298(3):E429–E439, pmid:19952344, Epub 2009 Dec 1.
    OpenUrlCrossRefPubMed
    1. Sato A,
    2. Kawano H,
    3. Notsu T,
    4. et al.
    (10, 2010) Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 59(10):2495–2504, pmid:20682690, Epub 2010 Aug 3.
    OpenUrlAbstract/FREE Full Text
    1. Tanaka N,
    2. Zhang X,
    3. Sugiyama E,
    4. et al.
    (11 15, 2010) Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol 80(10):1601–1612, pmid:20691165, Epub 2010 Aug 4.
    OpenUrlCrossRefPubMed
    1. Wada S,
    2. Yamazaki T,
    3. Kawano Y,
    4. Miura S,
    5. Ezaki O
    (9, 2008) Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice. J Hepatol 49(3):441–450, pmid:18620774, Epub 2008 Jun 11.
    OpenUrlCrossRefPubMedWeb of Science
    1. González-Périz A,
    2. Horrillo R,
    3. Ferré N,
    4. et al.
    (6, 2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23(6):1946–1957, pmid:19211925, Epub 2009 Feb 11.
    OpenUrlCrossRefPubMedWeb of Science
    1. Nobili V,
    2. Bedogni G,
    3. Alisi A,
    4. et al.
    (4, 2011) Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. Arch Dis Child 96(4):350–353, pmid:21233083, Epub 2011 Jan 12.
    OpenUrlAbstract/FREE Full Text
    1. Masterton GS,
    2. Plevris JN,
    3. Hayes PC
    (4, 2010) Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther 31(7):679–692, pmid:20415840.
    OpenUrlCrossRefPubMed
    1. Kenny D,
    2. Warltier DC,
    3. Pleuss JA,
    4. Hoffmann RG,
    5. Goodfriend TL,
    6. Egan BM
    (11 15, 1992) Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol 70(15):1347–1352, pmid:1442589.
    OpenUrlCrossRefPubMedWeb of Science
    1. Chin JP,
    2. Gust AP,
    3. Nestel PJ,
    4. Dart AM
    (1, 1993) Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 21(1):22–28, pmid:8418020.
    OpenUrlAbstract/FREE Full Text
    1. Harris WS,
    2. Rambjør GS,
    3. Windsor SL,
    4. Diederich D
    (2, 1997) N-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 65(2):459–464, pmid:9022531.
    OpenUrlAbstract/FREE Full Text
    1. Stirban A,
    2. Nandrean S,
    3. Götting C,
    4. et al.
    (3, 2010) Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. Am J Clin Nutr 91(3):808–813, pmid:20071644, Epub 2010 Jan 13.
    OpenUrlAbstract/FREE Full Text
    1. Leeson CP,
    2. Mann A,
    3. Kattenhorn M,
    4. Deanfield JE,
    5. Lucas A,
    6. Muller DP
    (2, 2002) Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood. Eur Heart J 23(23):216–222, pmid:11792136.
    OpenUrlCrossRefPubMedWeb of Science
    1. Dangardt F,
    2. Osika W,
    3. Chen Y,
    4. et al.
    (10, 2010) Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents. Atherosclerosis 212(2):580–585, pmid:20727522, Epub 2010 Jul 21.
    OpenUrlCrossRefPubMedWeb of Science
    1. Rizza S,
    2. Tesauro M,
    3. Cardillo C,
    4. et al.
    (10, 2009) Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis 206(2):569–574, pmid:19394939, Epub 2009 Mar 19.
    OpenUrlCrossRefPubMedWeb of Science
    1. Goodfellow J,
    2. Bellamy MF,
    3. Ramsey MW,
    4. Jones CJ,
    5. Lewis MJ
    (2, 2000) Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 35(2):265–270, pmid:10676668.
    OpenUrlFREE Full Text
    1. Mori TA,
    2. Watts GF,
    3. Burke V,
    4. Hilme E,
    5. Puddey IB,
    6. Beilin LJ
    (9 12, 2000) Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102(11):1264–1269, pmid:10982541.
    OpenUrlAbstract/FREE Full Text
    1. Wright SA,
    2. O'Prey FM,
    3. McHenry MT,
    4. et al.
    (6, 2008) A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 67(6):841–848, pmid:17875549, Epub 2007 Sep 17.
    OpenUrlAbstract/FREE Full Text
    1. Nestel P,
    2. Shige H,
    3. Pomeroy S,
    4. Cehun M,
    5. Abbey M,
    6. Raederstorff D
    (8, 2002) The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 76(2):326–330, pmid:12145002.
    OpenUrlAbstract/FREE Full Text
    1. McVeigh GE,
    2. Brennan GM,
    3. Cohn JN,
    4. Finkelstein SM,
    5. Hayes RJ,
    6. Johnston GD
    (9, 1994) Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 14(9):1425–1429, pmid:8068603.
    OpenUrlAbstract/FREE Full Text
    1. Farzaneh-Far R,
    2. Harris WS,
    3. Garg S,
    4. Na B,
    5. Whooley MA
    (8, 2009) Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 205(2):538–543, pmid:19185299, Epub 2008 Dec 14.
    OpenUrlCrossRefPubMedWeb of Science
    1. He K,
    2. Liu K,
    3. Daviglus ML,
    4. et al.
    (5 1, 2009) Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 103(9):1238–1243, pmid:19406265, Epub 2009 Mar 4.
    OpenUrlCrossRefPubMedWeb of Science
    1. Micallef MA,
    2. Munro IA,
    3. Garg ML
    (9, 2009) An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 63(9):1154–1156, pmid:19352379, Epub 2009 Apr 8.
    OpenUrlCrossRefPubMedWeb of Science
    1. van Bussel BC,
    2. Henry RM,
    3. Schalkwijk CG,
    4. et al.
    (9, 2011) Fish consumption in healthy adults is associated with decreased circulating biomarkers of endothelial dysfunction and inflammation during a 6-year follow-up. J Nutr 141(9):1719–1725, pmid:21753064, Epub 2011 Jul 13. Erratum in: J Nutr. 2011 Dec;141(12):2258.
    OpenUrlAbstract/FREE Full Text
    1. Zampelas A,
    2. Panagiotakos DB,
    3. Pitsavos C,
    4. et al.
    (7 5, 2005) Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol 46(1):120–124, pmid:15992645.
    OpenUrlFREE Full Text
    1. Murakami K,
    2. Sasaki S,
    3. Takahashi Y,
    4. et al.
    (5, 2008) Total n-3 polyunsaturated fatty acid intake is inversely associated with serum C-reactive protein in young Japanese women. Nutr Res 28(5):309–314, pmid:19083425.
    OpenUrlCrossRefPubMed
    1. Ferrucci L,
    2. Cherubini A,
    3. Bandinelli S,
    4. et al.
    (2, 2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91(2):439–446, pmid:16234304, Epub 2005 Oct 18.
    OpenUrlCrossRefPubMedWeb of Science
    1. Klein-Platat C,
    2. Drai J,
    3. Oujaa M,
    4. Schlienger JL,
    5. Simon C
    (12, 2005) Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82(6):1178–1184, pmid:16332649.
    OpenUrlAbstract/FREE Full Text
    1. Lopez-Garcia E,
    2. Schulze MB,
    3. Manson JE,
    4. et al.
    (7, 2004) Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134(7):1806–1811, pmid:15226473.
    OpenUrlAbstract/FREE Full Text
    1. Kelley DS,
    2. Siegel D,
    3. Fedor DM,
    4. Adkins Y,
    5. Mackey BE
    (3, 2009) DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 139(3):495–501, pmid:19158225, Epub 2009 Jan 21.
    OpenUrlAbstract/FREE Full Text
    1. Wang TM,
    2. Hsieh SC,
    3. Chen JW,
    4. Chiang AN
    (5, 2013) Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells. Mol Cell Biochem 377((1-2)):97–106, pmid:23361365, Epub 2013 January 30.
    OpenUrlPubMed
    1. Satoh N,
    2. Shimatsu A,
    3. Kotani K,
    4. et al.
    (11, 2009) Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome. Hypertens Res 32(11):1004–1008, pmid:19763135, Epub 2009 Sep 18.
    OpenUrlCrossRefPubMed
    1. McCarty MF
    (2014) Strategies for controlling serum amyloid A, a key mediator of the impact of systemic inflammation on cardiovascular disease, http://catalyticlongevity.org/strategies-for-controlling-serum-amyloid-a-a-key-mediator-of-the-impact-of-systemic-inflammation-on-cardiovascular-disease/. Accessed June 25.
    1. Serhan CN
    (10, 2010) Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 177(4):1576–1591, pmid:20813960, Epub 2010 Sep 2.
    OpenUrlCrossRefPubMedWeb of Science
    1. Nowak JZ
    (3 17, 2010) Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids [in Polish]. Postepy Hig Med Dosw (Online) 64:115–132, pmid:20354260.
    OpenUrlPubMed
    1. Serhan CN
    (1, 2005) Novel omega-3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther 105(1):7–21, pmid:15626453.
    OpenUrlCrossRefPubMedWeb of Science
    1. Serhan CN,
    2. Gotlinger K,
    3. Hong S,
    4. Arita M
    (4, 2004) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 73((3-4)):155–172, pmid:15290791.
    OpenUrlCrossRefPubMedWeb of Science
    1. Serhan CN,
    2. Arita M,
    3. Hong S,
    4. Gotlinger K
    (11, 2004) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39(11):1125–1132, pmid:15726828.
    OpenUrlCrossRefPubMedWeb of Science
    1. Serhan CN
    (3, 2005) Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care 8(2):115–121, pmid:15716788.
    OpenUrlCrossRefPubMedWeb of Science
    1. Serhan CN,
    2. Chiang N
    (3, 2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153((1)(suppl)):S200–S215, pmid:17965751, Epub 2007 Oct 29.
    OpenUrlCrossRefPubMedWeb of Science
    1. Serhan CN
    (Sep-Nov 2008) Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Prostaglandins Leukot Essent Fatty Acids 79((3-5)):157–163, pmid:19008087, Epub 2008 Nov 12.
    OpenUrlCrossRefPubMedWeb of Science
    1. Calviello G,
    2. Su HM,
    3. Weylandt KH,
    4. Fasano E,
    5. Serini S,
    6. Cittadini A
    (2013) Experimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases. Biomed Res Int 2013:Epub 2013 Apr 17. .
    1. Jones ML,
    2. Mark PJ,
    3. Keelan JA,
    4. et al.
    (8, 2013) Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. J Lipid Res 54(8):2247–2254, pmid:23723388, Epub 2013 May 30.
    OpenUrlAbstract/FREE Full Text
    1. Caughey GE,
    2. Mantzioris E,
    3. Gibson RA,
    4. Cleland LG,
    5. James MJ
    (1, 1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63(1):116–122, pmid:8604658.
    OpenUrlAbstract/FREE Full Text
    1. Kelley DS,
    2. Taylor PC,
    3. Nelson GJ,
    4. et al.
    (4, 1999) Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 34(4):317–324, pmid:10443964.
    OpenUrlCrossRefPubMedWeb of Science
    1. Trebble TM,
    2. Wootton SA,
    3. Miles EA,
    4. et al.
    (9, 2003) Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr 78(3):376–382, pmid:12936918.
    OpenUrlAbstract/FREE Full Text
    1. Rees D,
    2. Miles EA,
    3. Banerjee T,
    4. et al.
    (2, 2006) Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr 83(2):331–342, pmid:16469992.
    OpenUrlAbstract/FREE Full Text
    1. Vedin I,
    2. Cederholm T,
    3. Freund-Levi Y,
    4. et al.
    (5, 2010) Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study. J Lipid Res 51(5):1179–1185, pmid:19965584, Epub 2009 Nov 24.
    OpenUrlAbstract/FREE Full Text
    1. Sperling RI,
    2. Benincaso AI,
    3. Knoell CT,
    4. Larkin JK,
    5. Austen KF,
    6. Robinson DR
    (2, 1993) Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91(2):651–660, pmid:8381824.
    OpenUrlCrossRefPubMedWeb of Science
    1. An WS,
    2. Kim HJ,
    3. Cho KH,
    4. Vaziri ND
    (10 1, 2009) Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol 297(4):F895–F903, pmid:19656915, Epub 2009 Aug 5.
    OpenUrlCrossRefPubMedWeb of Science
    1. von Schacky C,
    2. Kiefl R,
    3. Jendraschak E,
    4. Kaminski WE
    (2, 1993) N-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo. J Lab Clin Med 121(2):302–309, pmid:8381847.
    OpenUrlPubMed
    1. Shearer GC,
    2. Harris WS,
    3. Pedersen TL,
    4. Newman JW
    (8, 2010) Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res 51(8):2074–2081, pmid:19671931, Epub 2009 Aug 11.
    OpenUrlAbstract/FREE Full Text
    1. Siegel G,
    2. Ermilov E
    (12, 2012) Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases. Atherosclerosis 225(2):291–295, pmid:23031363, Epub 2012 Sep 18.
    OpenUrlPubMed
    1. Rix TA,
    2. Christensen JH,
    3. Schmidt EB
    (3, 2013) Omega-3 fatty acids and cardiac arrhythmias. Curr Opin Clin Nutr Metab Care 16(2):168–173, pmid:23196815.
    OpenUrlPubMed
    1. Costanzo S,
    2. di Niro V,
    3. Di Castelnuovo A,
    4. et al.
    (10, 2013) Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis. J Thorac Cardiovasc Surg 146(4):906–911, pmid:23587470, Epub 2013 Apr 12.
    OpenUrlCrossRefPubMed
    1. Rix TA,
    2. Joensen AM,
    3. Lundbye-Christensen S,
    4. Riahi S,
    5. Schmidt EB,
    6. Overvad K
    (6, 2013) Moderate consumption of marine n-3 fatty acids is associated with a lower risk of atrial fibrillation - a cohort study [poster abstract]. Europace 15((suppl 2)). .
  84. ↵
    1. Mozaffarian D,
    2. Rimm EB
    (10 18, 2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296(15):1885–1899, pmid:17047219, Erratum in: JAMA. 2007 Feb 14;297(6):590.
    OpenUrlCrossRefPubMedWeb of Science
    1. von Schacky C,
    2. Angerer P,
    3. Kothny W,
    4. Theisen K,
    5. Mudra H
    (4 6, 1999) The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 130(7):554–562, pmid:10189324.
    OpenUrlCrossRefPubMedWeb of Science
    1. Mita T,
    2. Watada H,
    3. Ogihara T,
    4. et al.
    (3, 2007) Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis 191(1):162–167, pmid:16616147, Epub 2006 Apr 17.
    OpenUrlCrossRefPubMedWeb of Science
    1. Landmark K,
    2. Abdelnoor M,
    3. Kilhovd B,
    4. Dørum HP
    (1, 1998) Eating fish may reduce infarct size and the occurrence of Q wave infarcts. Eur J Clin Nutr 52(1):40–44, pmid:9481531.
    OpenUrlCrossRefPubMedWeb of Science
  88. ↵
    1. Landmark K,
    2. Abdelnoor M,
    3. Urdal P,
    4. et al.
    (1, 1998) Use of fish oils appears to reduce infarct size as estimated from peak creatine kinase and lactate dehydrogenase activities. Cardiology 89(2):94–102, pmid:9524009.
    OpenUrlCrossRefPubMedWeb of Science
  89. ↵
    1. Streppel MT,
    2. Ocké MC,
    3. Boshuizen HC,
    4. Kok FJ,
    5. Kromhout D
    (8, 2008) Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur Heart J 29(16):2024–2030, pmid:18641046, Epub 2008 Jul 18.
    OpenUrlCrossRefPubMedWeb of Science
  90. ↵
    1. Lemaitre RN,
    2. King IB,
    3. Mozaffarian D,
    4. Kuller LH,
    5. Tracy RP,
    6. Siscovick DS
    (2, 2003) N-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 77(2):319–325, pmid:12540389.
    OpenUrlAbstract/FREE Full Text
  91. ↵
    1. Yokoyama M,
    2. Origasa H,
    3. Matsuzaki M,
    4. et al.
    (3 31, 2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369(9567):1090–1098, pmid:17398308, Erratum in: Lancet. 2007 Jul 21;370(9583):220.
    OpenUrlCrossRefPubMedWeb of Science
  92. ↵
    1. McNamara RK
    1. Barringer TA,
    2. Harris WS
    (2013) in The Omega-3 Fatty Acid Deficiency Syndrome: Opportunities for Disease Prevention, Omega-3 fatty acid deficiency and cardiovascular disease, ed McNamara RK (Nova Science Publishers; New York, NY) In, ed, pp 213–232.
  93. ↵
    1. Kris-Etherton PM,
    2. Harris WS,
    3. Appel LJ
    (11, 2002) American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106(21):2747–2757, pmid:12438303, Erratum in: Circulation. 2003 Jan 28;107(3):512.
    OpenUrlFREE Full Text
  94. ↵
    1. Ministry of Health and Welfare
    (2000) Annual report of the National Nutrition Survey in 1998 [in Japanese] (Daiichi Publishing, Tokyo, Japan).
  95. ↵
    1. Sekikawa A,
    2. Curb JD,
    3. Ueshima H,
    4. et al.
    (8 5, 2008) Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 52(6):417–424, pmid:18672160.
    OpenUrlFREE Full Text
  96. ↵
    1. Sekikawa A,
    2. Kuller LH
    (1999) Coronary heart disease mortality in the United States among black and white men 35–44 years old by state. CVD Prev 2:212–221.
    OpenUrl
  97. ↵
    1. Takei H,
    2. Strong JP,
    3. Yutani C,
    4. Malcom GT
    (5, 2005) Comparison of coronary and aortic atherosclerosis in youth from Japan and the USA. Atherosclerosis 180(1):171–179, pmid:15823290, Epub 2005 Jan 26.
    OpenUrlCrossRefPubMedWeb of Science
  98. ↵
    1. Marchioli R,
    2. Barzi F,
    3. Bomba E,
    4. et al.
    (4 23, 2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105(16):1897–1903, pmid:11997274.
    OpenUrlAbstract/FREE Full Text
  99. ↵
    1. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial
    (8 7, 1999) Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354(9177):447–455, pmid:10465168, Erratum in: Lancet. 2001 Feb 24;357(9256):642. Lancet. 2007 Jan 13;369(9556):106.
    OpenUrlCrossRefPubMedWeb of Science
  100. ↵
    1. Gissi-HF Investigators,
    2. Tavazzi L,
    3. Maggioni AP,
    4. et al.
    (10 4, 2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372(9645):1223–1230, pmid:18757090, Epub 2008 Aug 29.
    OpenUrlCrossRefPubMedWeb of Science
  101. ↵
    1. Burr ML,
    2. Fehily AM,
    3. Gilbert JF,
    4. et al.
    (9 30, 1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2(8666):757–761, pmid:2571009.
    OpenUrlPubMedWeb of Science
  102. ↵
    1. Burr ML,
    2. Ashfield-Watt PA,
    3. Dunstan FD,
    4. et al.
    (2, 2003) Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57(2):193–200, pmid:12571649.
    OpenUrlCrossRefPubMedWeb of Science
  103. ↵
    1. Brouwer IA,
    2. Zock PL,
    3. Camm AJ,
    4. et al.
    (6 14, 2006) Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295(22):2613–2619, pmid:16772624.
    OpenUrlCrossRefPubMedWeb of Science
  104. ↵
    1. Rauch B,
    2. Schiele R,
    3. Schneider S,
    4. et al.
    (11 23, 2010) OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122(21):2152–2159, pmid:21060071, Epub 2010 Nov 8.
    OpenUrlAbstract/FREE Full Text
  105. ↵
    1. Kromhout D,
    2. Giltay EJ,
    3. Geleijnse JM
    (11 18, 2010) Alpha Omega Trial Group. N–3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363(21):2015–2026, pmid:20929341, Epub 2010 Aug 28.
    OpenUrlCrossRefPubMedWeb of Science
  106. ↵
    1. Galan P,
    2. Kesse-Guyot E,
    3. Czernichow S,
    4. et al.
    (Nov 29 2010) Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 341. .
  107. ↵
    1. Svensson M,
    2. Schmidt EB,
    3. Jørgensen KA,
    4. Christensen JH
    (7, 2006) OPACH Study Group. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol 1(4):780–786, pmid:17699287, Epub 2006 Jun 14.
    OpenUrlAbstract/FREE Full Text
  108. ↵
    1. Eritsland J,
    2. Arnesen H,
    3. Grønseth K,
    4. Fjeld NB,
    5. Abdelnoor M
    (1 1, 1996) Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 77(1):31–36, pmid:8540453.
    OpenUrlCrossRefPubMedWeb of Science
  109. ↵
    1. Rizos EC,
    2. Ntzani EE,
    3. Bika E,
    4. Kostapanos MS,
    5. Elisaf MS
    (9 12, 2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308(10):1024–1033, pmid:22968891.
    OpenUrlCrossRefPubMedWeb of Science
  110. ↵
    1. Lewis EJH
    (1 2, 2013) Omega-3 fatty acid supplementation and cardiovascular disease events [letter]. JAMA 309(1):27, pmid:23280208.
    OpenUrlPubMed
  111. ↵
    1. Vlachopoulos C,
    2. Richter D,
    3. Stefanadis C
    (1 2, 2013) Omega-3 fatty acid supplementation and cardiovascular disease events. JAMA 309(1):28, pmid:23280210.
    OpenUrlPubMed
  112. ↵
    1. Kwak SM,
    2. Myung SK,
    3. Lee YJ,
    4. Seo HG
    (5 14, 2012) Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 172(9):686–694, pmid:22493407.
    OpenUrlCrossRefPubMedWeb of Science
  113. ↵
    1. DiNicolantonio JJ,
    2. O'Keefe JH,
    3. Lavie CJ
    (10 8, 2012) The big ones that got away: omega-3 meta-analysis flawed by excluding the biggest fish oil trials. Arch Intern Med 172(18):1427, pmid:23045179.
    OpenUrlPubMed
  114. ↵
    1. Abuissa H,
    2. O'Keefe JH,
    3. Bybee KA
    (10, 2009) Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias. Clin Cardiol 32(10):549–552, pmid:19816987.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords